Healthcare: Dr Reddy's Laboratories SA has completed the acquisition through the purchase of shares of Northstar Switzerland ...

Dr Reddy's Laboratories on Monday said its Switzerland-based subsidiary has completed the acquisition of Haleon plc's global ...

Dr Reddy's Laboratories has completed the acquisition of Haleon plc's global Nicotine Replacement Therapy (NRT) portfolio, ...

Dr Reddy’s Laboratories SA, Switzerland, an arm of Dr Reddy’s Laboratories, has completed the previously-announced ...

Hyderabad-based pharma giant Dr Reddy’s Ltd finalizes its largest acquisition by buying British Haleon Plc’s non-US nicotine ...

DRL's Swiss subsidiary completed the acquisition through the purchase of shares of Northstar Switzerland SARL, a Haleon group ...

Dr. Reddy's invests $620 million in Swiss subsidiary for acquisition of global nicotine replacement therapy brands from Haleon.

Drug maker Dr Reddy's Laboratories Ltd on Friday (September 27) said it has invested $620 million in its wholly-owned ...

The funds infused by the company into Dr. Reddy's SA will be used for the acquisition of Nicotinell and related brands.

The nicotine replacement therapy market is mainly driven by increased smoking cessation programs, heightened health awareness, and the rising incidence of cancer due to ongoing tobacco use through ...